10x genomics stock price.
Two analysts rated the stock with a sell rating while eight assigned it a buy rating to date. In May 2023, CEO Serge Saxonov sold over two thousand shares of 10x Genomics’ stock at an average price of $55.06 per share for a total transaction value of $143,266.12. Other insiders also sold shares during this time.
Transcript : 10x Genomics, Inc. Presents at Stephens Annual Investment Conference | NASH 2023, Nov-14-2023 10:00 AM Nov. 14: CI UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating Nov. 07: MT10x Genomics offers a full set of software for analyzing the data produced by its equipment, ... The dramatic fall in stock price since 2021 might force a larger than planned dilution of existing shareholders. Similarly to 10x Genomics, the path to profitability is through most research labs adopting spatial biology routinely in their workflow.Get the latest 10x Genomics Inc. (TXG) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Nov 14, 2023 · 10X Genomics Inc Stock Price History. 10X Genomics Inc’s price is currently up 13.01% so far this month. During the month of November, 10X Genomics Inc’s stock price has reached a high of $40.08 and a low of $33.79. Over the last year, 10X Genomics Inc has hit prices as high as $63.57 and as low as $31.28. Year to date, 10X Genomics Inc’s ...
1,802.90 +23.50(+1.32%) Crude Oil 73.82 +0.92(+1.26%) Gold 1,991.60 +4.30(+0.22%) 10x Genomics, Inc. (TXG) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 39.94 -0.47...10x Genomics Inc - Class A () Stock Market info Recommendations: Buy or sell 10x Genomics Inc - Class A stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the 10x Genomics Inc - Class A share forecasts, stock quote and buy / sell signals below.According to present data 10x Genomics Inc - Class A's TXG shares …
10x Genomics (TXG) delivered earnings and revenue surprises of -15.79% and 4.22%, respectively, for the quarter ended March 2023. ... The sustainability of the stock's immediate price movement ...Nov 21, 2023 · According to 10 stock analysts, the average 12-month stock price forecast for 10x Genomics stock is $58.6, which predicts an increase of 34.90%. The lowest target is $30 and the highest is $75. On average, analysts rate 10x Genomics stock as a buy.
At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.TSLA Tesla, Inc. Common Stock $248.50 -2.99 -1.19% VFS VinFast Auto Ltd. Ordinary Shares $17.15 -0.84 -4.67% NVDA NVIDIA Corporation Common Stock $455.72 -6.69 -1.45% Investors may trade in the... Complete 10x Genomics Inc. stock information by Barron's. View real-time TXG stock price and news, along with industry-best analysis.Based on short-term price targets offered by 12 analysts, the average price target for 10x Genomics comes to $56.00. The forecasts range from a low of $30.00 to a high of $70.00. The average price ...10x Genomics was founded in 2012 by Serge Saxonov, Ben Hindson and Kevin Ness to create advanced testing equipment for use in cellular biology. [3] Prior to starting the company, Saxonov was the founding architect, and director of research and development at 23andMe. [2] Ness left 10x Genomics in December 2016 [4] and in 2018, Justin …
10x Genomics Inc experienced a daily loss of 5.62% and a 3-month loss of 12.81%.The company also reported a Loss Per Share of 1.49. Despite these figures, we aim to explore whether the stock is ...
According to 10 stock analysts, the average 12-month stock price forecast for 10x Genomics stock is $58.6, which predicts an increase of 33.85%. The lowest target is $30 and the highest is $75. On average, analysts rate 10x Genomics stock as a buy.
Serge Saxonov 10x Genomics (TXG) Stock Price Performance 10x Genomics (TXG) Stock Key Data Summary Additional Data Analysts Historical Quotes …Sep 8, 2023 · With a market cap of $5.60 billion and a stock price of $47.36 per share, it's worth comparing these figures to the estimated fair value of the stock, also known as the GF Value. May 24, 2023 · About 10x Genomics 10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics ... May 24, 2023 · About 10x Genomics 10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics ... 10x Genomics (TXG) delivered earnings and revenue surprises of -15.79% and 4.22%, respectively, for the quarter ended March 2023. ... The sustainability of the stock's immediate price movement ...Investor Relations. We are a life science technology company building products to interrogate, understand and master biology. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. We have built deep expertise across …Currently, 10X Genomics Inc does not have a price-earnings ratio. 10X Genomics Inc’s trailing 12-month revenue is $568.4 million with a -30.3% net profit margin. Year-over-year quarterly sales growth most recently was 28.1%. ... Overall, 10X Genomics Inc stock has a Value Score of 6, Estimate Revisions Score of 27 and Quality Score of 66.
Get 10x Genomics, Inc. (TXG) real-time share value, investment, rating and financial market information from Capital. ... To be able to trade stocks like this, create an account and apply for a stock listing. Create Account. Market Trading Hours* ... T. Rowe Price Associates, Inc. Investment Advisor: 2.5186: 2603267: 244613: 2023-06-30: LOW ...Nov 24, 2021 · Sure, at a price-to-sales ratio of 35, the stock looks expensive. But you get to own a dominant company that has plenty of runway to go. 10x Genomics has created its own market and is actively ... View the latest 10x Genomics Inc. (TXG) stock price, news, historical charts, analyst ratings and financial information from WSJ. Also, insider James Wilbur sold 14,718 shares of 10x Genomics stock in a transaction dated Monday, November 20th. The shares were sold at an average price of $42.09, for a total transaction of ...10x Genomics, Inc. Class A Common Stock (TXG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Get the latest 10X Genomics (TXG) stock forecast for tomorrow and next week. Stay ahead of the game with our 10X Genomics stock price prediction for 2025 ...
TXG | Complete 10x Genomics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
In the last 3 months, 5 analysts have offered 12-month price targets for 10x Genomics. The company has an average price target of $59.0 with a high of $65.00 and a low of $50.00. Below is a ...Aug 6, 2023 · In a recent research report, 10x Genomics (NASDAQ: TXG) has had its price objective increased by Barclays analysts from $65.00 to $66.00. The firm, which currently holds an “overweight” rating on the stock, believes that this price adjustment could potentially signify a significant upside of 15.47% from the stock’s current price. 10x Genomics, Inc. Class A Common Stock (TXG) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.For 10x Genomics stock forecast for 2023, 2 predictions are offered for each month of 2023 with average 10x Genomics stock forecast of $38.85, a high forecast of $38.92, and a low forecast of $38.77. The average 10x Genomics stock forecast 2023 represents a 0.87% increase from the last price of $38.5099983215332.8 analysts have issued 12 month target prices for 10x Genomics' stock. Their TXG share price targets range from $47.00 to $75.00. On average, they predict the company's stock price to reach $60.78 in the next twelve months. This suggests a possible upside of 42.3% from the stock's current price.Nov 17, 2023 · Investor Relations. We are a life science technology company building products to interrogate, understand and master biology. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. We have built deep expertise across diverse ...
According to 10 stock analysts, the average 12-month stock price forecast for 10x Genomics stock is $58.6, which predicts an increase of 33.85%. The lowest target is $30 and the highest is $75. On average, analysts rate 10x Genomics stock as a buy.
Based on short-term price targets offered by 12 analysts, the average price target for 10x Genomics comes to $56.00. The forecasts range from a low of $30.00 to a high of $70.00. The average price ...
UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating. Nov. 07. MT. OWKIN Integrates 10x Genomics, Inc. Spatial Omics and Single-Cell Technologies to the MOSAIC Study. Nov. 06. CI. Earnings Flash (TXG) 10X GENOMICS Reports Q3 Revenue $153.6M, vs. Street Est of $151.3M. Nov. 02.Nov 14, 2023 · 10X Genomics Inc Stock Price History. 10X Genomics Inc’s price is currently up 13.01% so far this month. During the month of November, 10X Genomics Inc’s stock price has reached a high of $40.08 and a low of $33.79. Over the last year, 10X Genomics Inc has hit prices as high as $63.57 and as low as $31.28. Year to date, 10X Genomics Inc’s ... Sure, at a price-to-sales ratio of 35, the stock looks expensive. But you get to own a dominant company that has plenty of runway to go. 10x Genomics has created its own market and is actively ...10x Genomics is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. ... Note that our analysis may not factor in the latest price-sensitive company ...Sure, at a price-to-sales ratio of 35, the stock looks expensive. But you get to own a dominant company that has plenty of runway to go. 10x Genomics has created its own market and is actively ...Mar 31, 2023 · The company has an average price target of $59.0 with a high of $65.00 and a low of $50.00. Below is a summary of how these 5 analysts rated 10x Genomics over the past 3 months. Get the latest 10x Genomics Inc. (TXG) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.In mid-2024, 10x Genomics plans to launch 5,000 plex gene panels for mouse and human tissues that run in days – not weeks – and deliver high levels of specificity, sensitivity and throughput. Also in 2024, 10x Genomics expects to launch an in-line protein assay to combine with the RNA assays on the exact same tissue section.Since 10X Genomics Inc last announced earnings on 8/3/2023, its stock price has fallen 4.8% as of 8/8/2023. In comparison, the SPDR S&P; 500 ETF Trust (SPY) has risen 0.4% during that same time period. Important 10X Genomics Inc Earnings Metrics to Analyze. As of 8/8/2023, 10X Genomics Inc has a trailing 12-month earnings per share of $-1.69.10x Genomics is a life sciences company trading at 8x P/S and 4.9x P/B. Read why I do not recommend taking a long position in TXG stock. ... Insiders have also been selling stock and sale prices ...Regardless, money keeps flowing into the gene editing space, and these three CRISPR stocks are worthy of investors’ attention going forward. CRSP. CRISPR. $57.47. EDIT. Editas. $11.70. TXG. 10x ...
May 25, 2023 · It could be an inflection year for 10x Genomics, one analyst says. TXG stock bounded off a low in October and is now on a seven-month sprint. ... 9/12/2023 10x Genomics shows rising price ... 10x Genomics Cloud Analysis enables you to process your single cell gene expression data through a simple web interface, leveraging an optimized, scalable infrastructure for fast results. Users can set up and run Cell Ranger pipelines through Cloud Analysis. Cell Ranger is a set of analysis pipelines that will automatically generate expression profiles for each …At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Instagram:https://instagram. apps that simulate stock marketfnbtwhat's the best company to invest individends johnson and johnson If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Feb 15, 2023 · 10x Genomics (TXG) delivered earnings and revenue surprises of 48.28% and 6.50%, respectively, for the quarter ended December 2022. ... The sustainability of the stock's immediate price movement ... this weeks stock marketprice of a kennedy half dollar Stock Price Forecast. The 12 analysts offering 12-month price forecasts for 10X Genomics Inc have a median target of 60.00, with a high estimate of 70.00 and a low estimate of 30.00.10x Genomics Cloud Analysis enables you to process your single cell gene expression data through a simple web interface, leveraging an optimized, scalable infrastructure for fast results. Users can set up and run Cell Ranger pipelines through Cloud Analysis. Cell Ranger is a set of analysis pipelines that will automatically generate expression profiles for each … emerson electric co stock Sure, at a price-to-sales ratio of 35, the stock looks expensive. But you get to own a dominant company that has plenty of runway to go. 10x Genomics has created its own market and is actively ...10x Genomics stock price target cut to $115 from $200 at Stifel Nicolaus Feb. 17, 2022 at 7:24 a.m. ET by Tomi Kilgore 10x Genomics downgraded to neutral from buy at BofA …